| Mitazalimab | ADC-1013; JNJ-7107; JNJ-64457107 | Phase 3 Clinical | Alligator Bioscience Ab | Biliary Tract Neoplasms; Breast Neoplasms; Carcinoma, Pancreatic Ductal; Neoplasms; Pancreatic Neoplasms; Solid tumours | 詳細 |
| CD40L-GVAX | GM.CD40L; CD40L-GVAX; GM-CSF/CD40L; hCD40L/hGM-CSF | Phase 2 Clinical | University Of South Florida | Adenocarcinoma; Adenocarcinoma of Lung; Leukemia; Lung Neoplasms; Melanoma; Myelodysplastic Syndromes; Skin Melanoma | 詳細 |
| BI-655064 | BI-655064 | Phase 2 Clinical | C.H. Boehringer Sohn Ag & Co. Kg | Arthritis, Rheumatoid; Lupus Nephritis; Purpura, Thrombocytopenic, Idiopathic | 詳細 |
| Sotigalimab | APX-005M; EPI-0050; APX-005 | Phase 2 Clinical | Epitomics Inc | Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Carcinoma, Transitional Cell; Esophageal Neoplasms; Head and Neck Neoplasms; Lung Neoplasms; Melanoma; Microsatellite Instability; Neoplasms; Pancreatic Neoplasms; Skin Melanoma; Skin Neoplasms; Stomach Neoplasms | 詳細 |
| Iscalimab | NVP-CFZ533; OM11-62-MF; CFZ-533 | Phase 2 Clinical | Novartis Pharma Ag | Arthritis, Rheumatoid; Diabetes Mellitus, Type 1; Graves Disease; Hidradenitis Suppurativa; Lupus Erythematosus, Systemic; Lupus Nephritis; Myasthenia Gravis; Rejection of renal transplantation; Rejection of liver transplantation; Sjogren's Syndrome; Sjogren-Larsson Syndrome | 詳細 |
| Anti-CD40 ChiLob7/4 (BioNTech) | | Phase 2 Clinical | Biontech Se | Head and Neck Neoplasms; Pancreatic Neoplasms | 詳細 |
| CDX-1140 | CDX-1140 | Phase 2 Clinical | Celldex Therapeutics | Bile Duct Neoplasms; Biliary Tract Neoplasms; Breast Neoplasms; Carcinoma; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Cholangiocarcinoma; Colorectal Neoplasms; Esophageal Neoplasms; Fallopian Tube Neoplasms; Head and Neck Neoplasms; Hypopharyngeal Neoplasms; Laryngeal Neoplasms; Leukemia, Lymphocytic, Chronic, B-Cell; Liver Neoplasms; Lung Neoplasms; Lymphoma, B-Cell; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Mantle-Cell; Lymphoma, Non-Hodgkin; Melanoma; Metastatic breast cancer; Mouth Neoplasms; Nasopharyngeal Carcinoma; Oral Squamous Cell Carcinoma; Oropharyngeal Neoplasms; Oropharyngeal Squamous Cell Carcinoma (OPSCC); Ovarian Neoplasms; Pancreatic Neoplasms; Peritoneal Neoplasms; Solid tumours; Squamous Cell Carcinoma of Head and Neck; Stomach Neoplasms; Uveal melanoma; Waldenstrom Macroglobulinemia | 詳細 |
| Bleselumab | 4D-11; ASKP-1240 | Phase 2 Clinical | Kyowa Hakko Kogyo Co Ltd | Glomerulosclerosis, Focal Segmental; Psoriasis; Rejection of renal transplantation; Rejection of organ transplantation | 詳細 |
| Tecaginlimab | BNT-312; GEN-1042 | Phase 2 Clinical | Genmab A/S | Carcinoma, Non-Small-Cell Lung; Carcinoma, Pancreatic Ductal; Colorectal Neoplasms; Melanoma; Solid tumours; Squamous Cell Carcinoma of Head and Neck | 詳細 |
| MP-0317 | MP-0317 | Phase 2 Clinical | Molecular Partners Ag | Biliary Tract Neoplasms; Solid tumours | 詳細 |
| ABBV-9832 | ABBV-9832 | Phase 2 Clinical | Abbvie Inc | | 詳細 |
| Ravagalimab | ABBV-323; PR-1629977 | Phase 2 Clinical | Abbvie Inc | Colitis, Ulcerative; Sjogren's Syndrome | 詳細 |
| DFI-105 | DFI105; DFI-105 | Phase 2 Clinical | Diabetes Free Inc | Diabetes Mellitus, Type 2 | 詳細 |
| SHR-2005 | SHR2005; SHR-2005 | Phase 2 Clinical | Shanghai Hengrui Pharmaceutical Co Ltd | Urinary Bladder Neoplasms | 詳細 |
| SV-102 | SV-102; SV102; SYNC-T SV-102 | Phase 2 Clinical | Syncromune Inc | Prostatic Neoplasms, Castration-Resistant | 詳細 |
| SHR-7367 | SHR7367; SHR-7367 | Phase 2 Clinical | Shanghai Hengrui Pharmaceutical Co Ltd | | 詳細 |
| Cifurtilimab | SEA-1C10; SEA-CD40 | Phase 2 Clinical | Seagen Inc | Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Head and Neck Neoplasms; Hodgkin Disease; Lymphoma; Lymphoma, B-Cell; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Melanoma; Neoplasm Metastasis; Neoplasms, Squamous Cell; Pancreatic Neoplasms; Squamous Cell Carcinoma of Head and Neck | 詳細 |
| TQB-2916 | TQB2916; TQB-2916 | Phase 2 Clinical | Nanjing Shunxin Pharmaceuticals Co Ltd Of Chiatai Tianqing Pharmaceutical Group | Melanoma; Neoplasms; Pancreatic Neoplasms; Sarcoma | 詳細 |
| MIL-97 | MIL-97 | Phase 2 Clinical | Beijing Mabworks Biotech Co Ltd | Pancreatic Neoplasms; Solid tumours | 詳細 |
| Dalnicastobart | LVGN7409; LVGN-7409 | Phase 2 Clinical | Lyvgen Biopharma(HK)Ltd | Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Esophageal Neoplasms; Head and Neck Neoplasms; Neoplasm Metastasis; Neoplasms; Ovarian Neoplasms; Papillomavirus Infections; Sarcoma; Solid tumours; Stomach Neoplasms; Uveal melanoma | 詳細 |
| OPT-101 | OPT-101 | Phase 2 Clinical | Op-T LLC | Diabetes Mellitus, Type 1; Pneumonia; Sepsis | 詳細 |
| 2141-V11 | 2141-V11 | Phase 2 Clinical | The Rockefeller University | Ganglioglioma; Glioblastoma; Glioma; Neoplasms; Prostatic Neoplasms; Skin Neoplasms; Solid tumours; Urinary Bladder Neoplasms | 詳細 |
| Ciltistotug | YH003; YH-003 | Phase 2 Clinical | | Carcinoma, Pancreatic Ductal; Melanoma; Pancreatic Neoplasms; Solid tumours | 詳細 |
| Abiprubart | KPL-404 | Phase 2 Clinical | Beth Israel Deaconess Medical Center | Arthritis, Rheumatoid; Sjogren's Syndrome | 詳細 |
| NJA-730 | NJA-730; NJA-730a; NJA-730b | Phase 1 Clinical | Napajen Pharma | | 詳細 |
| Autologous IL2 and CD40 ligand-expressing tumor cells (Baylor College of Medicine) | | Phase 1 Clinical | Baylor College Of Medicine | Leukemia, Lymphocytic, Chronic, B-Cell | 詳細 |
| Giloralimab | ABBV-927 | Phase 1 Clinical | Abbvie Inc | Carcinoma, Non-Small-Cell Lung; Head and Neck Neoplasms; Neoplasms; Pancreatic Neoplasms; Solid tumours; Triple Negative Breast Neoplasms | 詳細 |
| NG-350A | NG-350A | Phase 1 Clinical | Akamis Bio Ltd | Neoplasm Metastasis; Neoplasms, Glandular and Epithelial; Rectal Neoplasms | 詳細 |
| SL-172154 | SL-172154; SIRPα -Fc-CD40L | Phase 1 Clinical | Shattuck Labs Inc | Carcinoma, Ovarian Epithelial; Carcinoma, Squamous Cell; Fallopian Tube Neoplasms; Leukemia, Myeloid, Acute; Myelodysplastic Syndromes; Ovarian Neoplasms; Peritoneal Neoplasms; Squamous Cell Carcinoma of Head and Neck | 詳細 |
| recombinant adenovirus vector vaccine targeting MUC1 (MicroVax) | | Phase 1 Clinical | Microvax Llc | | 詳細 |
| HIV ANTI-CD40.ENV GP140 | | Phase 1 Clinical | LinKinVax | | 詳細 |
| PeptiCRAd-1 | Valo-D102; PeptiCRAd-1 | Phase 1 Clinical | Valor Biotherapeutics | Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Liposarcoma, Myxoid; Neoplasms; Osteosarcoma; Sarcoma; Sarcoma, Synovial; Skin Melanoma; Triple Negative Breast Neoplasms | 詳細 |
| CD40xFAP bispecific antibody (Bristol-Myers Squibb Company) | | Phase 1 Clinical | Bristol-Myers Squibb Company | | 詳細 |
| M-0324 | M-0324; M0324 | Phase 1 Clinical | Merck KGaA, Darmstadt, Germany | | 詳細 |
| KK-2269 | KK-2269; KK2269 | Phase 1 Clinical | Kyowa Kirin Inc | Carcinoma, Non-Small-Cell Lung; Esophageal adenocarcinoma; Gastroesophageal Junction Neoplasms; Solid tumours; Stomach Neoplasms | 詳細 |
| LNF-1901 | LNF-1901; LNF1901 | Phase 1 Clinical | Lunan Pharmaceutical Group Co | | 詳細 |
| B-901 | B-901; B901 | Phase 1 Clinical | FutureGen Biopharm (Beijing) Co Ltd | | 詳細 |
| SHR-1704 | SHR-1704 | Phase 1 Clinical | Jiangsu Hengrui Medicine Co Ltd | | 詳細 |
| IMB-071703 | IMB-071703; IMB071703 | Phase 1 Clinical | Beijng Immunoah Pharma Tech Co Ltd | | 詳細 |
| ILB-2101 | ILB-2101 | Phase 1 Clinical | Innolake Biopharm (Hangzhou) Co Ltd | | 詳細 |
| HBM-9027 | HBM-9027; HBM9027 | Phase 1 Clinical | Harbour Biomed | | 詳細 |
| BSI-038 | BSI-038 | Phase 1 Clinical | Biosion Inc | | 詳細 |
| RO-7300490 | RO-7300490; RG-6189; FAP-CD40; FAP-huCD40 | Phase 1 Clinical | F. Hoffmann-La Roche Ltd | | 詳細 |
| Inezetamab | AMG-994 | Phase 1 Clinical | Amgen Inc | | 詳細 |
| BMS-986325 | Y 12XX-hz28-P238K | Phase 1 Clinical | Bristol-Myers Squibb Company | | 詳細 |
| NWY-001(Biocytogen Pharmaceuticals) | NWY001(Biocytogen Pharmaceuticals); YH008; YH-008; NWY-001(Biocytogen Pharmaceuticals) | Phase 1 Clinical | | Hematologic Neoplasms; Neoplasms; Solid tumours | 詳細 |